LABCORP HOLDINGS INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
LABCORP HOLDINGS INC. (LH) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $8.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-24
- LABCORP HOLDINGS INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was $8.30M, a 20.29% increase from fiscal 2024.
- LABCORP HOLDINGS INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $6.90M, a 30.30% decline from fiscal 2023.
- LABCORP HOLDINGS INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $9.90M.
- LABCORP HOLDINGS INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2019 was $30.00M, a 408.47% increase from fiscal 2018.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2025-12-31 | $8.30M 10-K · filed 2026-02-24 |
| 2024-12-31 | $6.90M 10-K · filed 2026-02-24 |
| 2023-12-31 | $9.90M 10-K · filed 2026-02-24 |
| 2019-12-31 | $30.00M 10-K · filed 2020-02-28 |
| 2018-12-31 | $5.90M 10-K · filed 2020-02-28 |
| 2017-12-31 | $2.00M 10-K · filed 2020-02-28 |
| 2016-12-31 | $1.20M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |